Insider Transactions in Q1 2024 at 89bio, Inc. (ETNB)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,350,000
+9.8%
|
$20,250,000
$15.35 P/Share
|
|
Feb 26
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,477
-0.91%
|
$44,770
$10.76 P/Share
|
|
Feb 17
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
778
-0.72%
|
$7,002
$9.74 P/Share
|
|
Feb 17
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,046
-0.47%
|
$9,414
$9.74 P/Share
|
|
Feb 17
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,602
-0.93%
|
$41,418
$9.74 P/Share
|
|
Feb 17
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,046
-0.66%
|
$9,414
$9.74 P/Share
|
|
Feb 09
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,568
-3.22%
|
$28,544
$8.45 P/Share
|
|
Feb 09
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
3,568
-1.57%
|
$28,544
$8.45 P/Share
|
|
Feb 09
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,568
-2.19%
|
$28,544
$8.45 P/Share
|
|
Feb 09
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,670
-2.57%
|
$101,360
$8.45 P/Share
|
|
Feb 05
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,190
-0.52%
|
$10,710
$9.8 P/Share
|
|
Feb 05
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,190
-0.72%
|
$10,710
$9.8 P/Share
|
|
Feb 05
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,068
-1.02%
|
$45,612
$9.8 P/Share
|
|
Feb 05
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
892
-0.8%
|
$8,028
$9.8 P/Share
|
|
Feb 01
2024
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
48,750
+17.62%
|
-
|
|
Feb 01
2024
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,750
+22.89%
|
-
|
|
Feb 01
2024
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+23.12%
|
-
|
|
Feb 01
2024
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,750
+30.36%
|
-
|
|
Jan 05
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,671
-7.73%
|
$106,381
$11.53 P/Share
|
|
Jan 05
2024
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+16.65%
|
-
|
|
Jan 05
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,124
-8.85%
|
$67,364
$11.53 P/Share
|
|
Jan 05
2024
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+17.81%
|
-
|
|
Jan 05
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,511
-7.31%
|
$302,621
$11.53 P/Share
|
|
Jan 05
2024
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+16.62%
|
-
|
|
Jan 05
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
9,671
-5.12%
|
$106,381
$11.53 P/Share
|
|
Jan 05
2024
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+11.69%
|
-
|